Riskpilot← Back to searchSign inGet full accessHåman Medical AB
ABDissolvedOrg 5590098595Medical specialists activities · NACE 8622Est. 20155 employees
Revenue 2022
SEK 11,1M
+11% vs 2021
EBITDA margin
43.6%
+7% vs 2021
Equity ratio
91.1%
Financial strength
Net profit 2022
SEK 3,9M
-43% vs 2021
| Revenue | SEK 11,1M | +11% |
| EBITDA | SEK 4,9M | +7% |
| Net profit | SEK 3,9M | -43% |
| Total assets | SEK 4,3M | -58% |
| Equity | SEK 3,9M | -58% |
| Employees | 5 | — |
Legal name
Håman Medical AB
Org number
5590098595
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 april 2015
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva läkarbehandlingar inom slutenvårds- kliniker för somatisk sjukvård och specialistläkarmottagningar inom öppenvård inom gynekologi, barn, hud, ortopedi, samt öron, näsa, hals och ögonmottagningen samt import och export av läkemedel och instrument som är avsedda att användas på sjukhus, men kan också vara en del av ambulansbilarnas utrustning.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 10 570 | 10 956 | 9 453 | 10 001 | 11 147 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 666 | 6 290 | 4 069 | 4 522 | 4 856 |
| Depreciation & amort. | −67 | −67 | −67 | −57 | −0 |
| EBIT | 6 599 | 6 223 | 4 002 | 4 465 | 4 856 |
| Net financials | — | −9 | −9 | −2 | −2 |
| Profit before tax | 4 949 | 6 214 | 2 997 | 8 657 | 4 853 |
| Tax | −1 090 | −1 370 | −645 | −1 884 | −1 000 |
| Net profit | 3 859 | 4 844 | 2 352 | 6 773 | 3 853 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 11 880 | 15 103 | 7 067 | 10 166 | 4 284 |
| Equity | 6 428 | 10 197 | 2 550 | 9 323 | 3 903 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 253 | 1 707 | 323 | 843 | 381 |
| Total debt | 2 253 | 1 707 | 323 | 843 | 381 |
EBITDA margin
43.6%
This company
15.8%
Market median
+176% vs market
20182022
Equity ratio
91.1%
This company
38.2%
Market median
+138% vs market
20182022
Return on equity
98.7%
This company
18.4%
Market median
+436% vs market
20182022
Net profit margin
34.6%
This company
8.1%
Market median
+327% vs market
20182022
Asset turnover
2.60×
This company
1.12×
Market median
+132% vs market
20182022
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LE Audit | Audit | 2022 |
AM Auditor Substitute | Auditor Substitute | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Håman Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars-Erik Engberg | Audit | 0 companies |
| Anna Maria Wretholm | Auditor Substitute | 0 companies |
| Lazha Kadir | Deputy Board Member | 0 companies |
| Awder Mustafa | Board of Directors | 0 companies |